1. Thrombin-Activable Fibrinolysis Inhibitor v Hashimotos
    Bob Bob United Kingdom says:
    October 5, 2009 at 4:46 PM

    http://dx.doi.org/10.2169/internalmedicine.48.1758

    The Effect of Hormone Replacement Treatment on Thrombin-Activatable Fibrinolysis Inhibitor Activity Levels in Patients with Hashimoto Thyroiditis

    Intern Med. 2009;48(5):281-5. Epub 2009 Mar 2.

    Sevki Cetinkalp 1, Mahmut Tobu 2, Muammer Karadeniz 1, Filiz Buyukkeçeci 2
    and Candeger Yilmaz 1

    1 Division of Endocrinology and Metabolism, Department of Internal Medicine, Ege University Hospital, Izmir, Turkey and

    2 Division of Hematology, Department of Internal Medicine,
    Ege University Hospital, Izmir, Turkey
    Received for publication October 7, 2008; Accepted for publication November 11, 2008

    Reply
The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
(Logout)
Post

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback